SEC Form 4 · accession 0001140361-26-032816
ROCKET PHARMACEUTICALS, INC. · RCKT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarbani Chaudhuri
Officer — See Remarks
Period of report
Aug 11, 2026
Accepted (ET)
Aug 13, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001281895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 11, 2026 | S | 4,701 | $3.499 | D | 262,809 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- F2The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Remarks
Chief Commercial & Medical Affairs Officer